Delivery Order SPE2DB25D3201-SPE2DB26FNNNJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Bromfenac Sodium 0.09% eye drops in 1.7ml units, with a ceiling value of $1,873.23. This non-competitive, firm fixed price delivery order is scheduled for completion by September 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Bromfenac Sodium 0.09% eye drops in 1.7mL units, with a contract ceiling value of $9,699.75. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of May 21, 2025. The delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,328.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Bromfenac Sodium 0.09% eye drops (1.7 mL) on June 5, 2025, with an ultimate completion date of June 6, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement from the vendor's place of performance in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Bromfenac Sodium 0.09% eye drops. This $1,488.72 contract has a performance period through March 21, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $4,236.38 firm fixed-price contract is for the supply of 4565951611 - Bromfenac Sodium 0.09% Eye Drops in 1.7 milliliter containers. The contract has an ultimate completion date of September 27, 2024. Amerisourcebergen Drug Corp is a for-profit organization and holds significant Indefinite Delivery Contracts (IDCs) with DLA Troop...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The award is for the provision of Bromfenac Sodium 0.09% Eye Drops in 1.7ml containers, with a total ceiling value of $1,131.37 and a period of performance through March 12, 2024. The award is part of a larger indefinite delivery contract (IDC) valued at up to...
- This $38,872.30 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4,562,911,110 units of Bromfenac Sodium 0.09% Eye Drops, 1.7 ml, to be delivered by November 28, 2023. No set-aside designation was used for this award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical worth $1,709.50 to supply 4562705526 Bromfenac Sodium 0.09% Eye Drops 1.7mL by November 6, 2023. The delivery order was awarded against an indefinite delivery contract on November 3, 2023 with no set aside designation specified. Performance will take place at Amerisourcebergen's facility located in Conshohocken, Pennsylvania. As a leading pharmaceutical...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a firm fixed price delivery order for $1,313.73 from the Defense Logistics Agency (DLA) Troop Support Medical to supply Bromfenac Sodium 0.09% Eye Drops 1.7mL. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by November 17, 2023. No set-aside designation was used for this award made against an indefinite delivery contract held by Amerisourcebergen Drug Corp to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bromfenac Sodium 0.09% eye drops in 1.7 mL vials. The contract has a firm fixed price, with a ceiling value of $1,457.11, and a performance period that runs through July 1, 2025. This contract is not set aside for any specific business type. AmerisourceBergen Drug Corp...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB26FNNNJDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on October 22, 2025, by the Defense Logistics Agency to supply Bromfenac Sodium 0.09% eye drops in 1.7-milliliter units. The contract is valued at $4,516.24 with a firm fixed price structure and an ultimate completion date of October 23, 2025. This award was competitively awarded with no set-aside designation and represents a direct delivery order under AmerisourceBergen Drug Corp's larger indefinite delivery vehicle with DLA Troop Support Medical. This delivery order falls under AmerisourceBergen Drug Corp's comprehensive Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. The Bromfenac Sodium ophthalmic product being procured supports the Defense Health Agency's medical supply requirements and reflects AmerisourceBergen Drug Corp's role as a critical pharmaceutical vendor for federal military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 10/22/25 |